Pages that link to "Q36080426"
Jump to navigation
Jump to search
The following pages link to EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary Group (Q36080426):
Displaying 23 items.
- Immunotherapy for advanced renal cell cancer (Q24187300) (← links)
- Immunotherapy for advanced renal cell cancer (Q24246777) (← links)
- Immunotherapy for metastatic renal cell carcinoma (Q30234458) (← links)
- Immunotherapy for advanced renal cell cancer. (Q30887373) (← links)
- Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature (Q33990034) (← links)
- Renal cell carcinoma: diagnosis and treatment, 1994-2003. (Q34081741) (← links)
- Metastatic tumors to the pancreas: The role of surgery (Q34443793) (← links)
- Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma (Q34552919) (← links)
- The biological treatment of renal-cell carcinoma and melanoma (Q34569970) (← links)
- Immunotherapy for renal cell carcinoma (Q35157638) (← links)
- Kidney cancer: identification of novel targets for therapy (Q36366495) (← links)
- Systemic therapy for metastatic renal cell carcinoma: a review and update. (Q38092779) (← links)
- Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma (Q38860651) (← links)
- Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study (Q39853218) (← links)
- Surgical treatment of a solitary pancreatic metastasis from renal cell carcinoma: Report of a case (Q41722274) (← links)
- Role of everolimus in the treatment of renal cell carcinoma (Q42560493) (← links)
- Successful treatment with novel triple drug combination consisting of interferon-gamma, interferon alfacon-1, and ribavirin in a nonresponder HCV patient to pegylated interferon therapy (Q43000510) (← links)
- Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: a phase II study (Q45090159) (← links)
- EORTC scientific strategy meeting 25-26 March 1999. (Q53530286) (← links)
- Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis. (Q53612481) (← links)
- Current role of interventions in metastatic kidney tumors: single center experience (Q56776031) (← links)
- Cytokine therapy in renal cell cancer (Q59571931) (← links)
- Role of recombinant interferon-gamma maintenance in responding patients with small cell lung cancer. A randomised phase III study of the EORTC Lung Cancer Cooperative Group (Q74202011) (← links)